Investors seeking to outperform the market often focus on hand-picking stocks. Selecting the right ones has proven to be a key factor in boosting wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Clearside Biomedical Inc (NASDAQ: CLSD) closed the day trading at $1.20 down -8.40% from the previous closing price of $1.31. In other words, the price has decreased by -$8.40 from its previous closing price. On the day, 0.61 million shares were traded. CLSD stock price reached its highest trading level at $1.2997 during the session, while it also had its lowest trading level at $1.14.
Ratios:
For a better understanding of CLSD, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 5.07 and its Current Ratio is at 5.07.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Chardan Capital Markets on August 21, 2024, initiated with a Buy rating and assigned the stock a target price of $6.
On June 25, 2024, Oppenheimer started tracking the stock assigning a Outperform rating and target price of $5.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jun 24 ’24 when Chong Ngai Hang Victor bought 23,500 shares for $1.06 per share. The transaction valued at 24,910 led to the insider holds 63,500 shares of the business.
YERXA BENJAMIN R bought 7,813 shares of CLSD for $10,235 on May 15 ’24. The Director now owns 17,957 shares after completing the transaction at $1.31 per share. On Apr 18 ’24, another insider, Gibney Anthony S, who serves as the Director of the company, bought 93,290 shares for $1.30 each. As a result, the insider paid 121,277 and bolstered with 100,000 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CLSD now has a Market Capitalization of 89694720 and an Enterprise Value of 107928688. For the stock, the TTM Price-to-Sale (P/S) ratio is 11.93. Its current Enterprise Value per Revenue stands at 14.345 whereas that against EBITDA is -4.206.
Stock Price History:
Over the past 52 weeks, CLSD has reached a high of $2.12, while it has fallen to a 52-week low of $0.65. The 50-Day Moving Average of the stock is 7.52%, while the 200-Day Moving Average is calculated to be -5.50%.
Shares Statistics:
Over the past 3-months, CLSD traded about 247.52K shares per day on average, while over the past 10 days, CLSD traded about 455650 shares per day. A total of 74.75M shares are outstanding, with a floating share count of 63.26M. Insiders hold about 15.36% of the company’s shares, while institutions hold 21.28% stake in the company. Shares short for CLSD as of 1724976000 were 335170 with a Short Ratio of 1.35, compared to 1722384000 on 206864. Therefore, it implies a Short% of Shares Outstanding of 335170 and a Short% of Float of 0.47999998000000005.
